Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.
All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.
How it describes itself
Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.
July 2021 – October 2026 · 4 captures · latest observed messagingAdvancing the Next Generation of Antibody Drugs
Our technology at GigaGen uniquely captures and recreates complete immune repertoires as functional antibody libraries to revolutionize antibody drug discovery and development.
9 July 2021 · Advancing the Next Generation of Antibody Drugsarchived page
7 February 2023 · Advancing the Next Generation of Antibody Drugsarchived page
1 January 2025 · Advancing the Next Generation of Antibody Drugsarchived page
3 October 2026 · Advancing the Next Generation of Antibody Drugsarchived page
January 2018 – July 2019 · 2 capturesOvercoming Immune Dysregulation to Fight Disease
GigaGen’s proprietary approach delivers unprecedented insights into immune regulatory pathways and what causes them to fail, enabling a pipeline of novel antibody therapies for patients with cancer an
July 2012 – September 2014 · 2 capturesGigaGen | Technology and services for immunogenetics
Capture your immune-ome. GigaGen's Cell-Seq technology generates an immune molecular "fingerprint" for diagnostics in transplantation, autoimmunity, and cancer.